Stockholder's Equity (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of share-based payment award, stock options, valuation assumptions

The weighted average assumptions utilized to determine the fair value of options granted during the three months ended March 31, 2024 and 2023 are as follows:

	Three Months Ended March 31,
	2024		2023
Risk-free interest rate	4.36	%	4.49	%
Expected volatility	48.63	%	43.93	%
Expected life (in years)	4.32		4.30
Dividend yield	0	%	0	%

Schedule of share-based compensation, employee stock purchase plan

The following table presents stock-based compensation expense, including expense for the ESPP, in the Company's consolidated statements of operations for the three months ended March 31, 2024 and 2023, respectively:

	Three Months Ended March 31,
	2024		2023
Cost of service sales	$	7	$	4
Cost of product sales	9		7
Research and development	89		88
Sales, marketing and support	71		38
General and administrative	346		159
	$	522	$	296

Schedule of accumulated other comprehensive income (loss)

The balances for the three months ended March 31, 2024 and 2023 are as follows:

	Foreign Currency Translation		Unrealized (Loss) Gain on Available for Sale Marketable Securities		Total Accumulated Other Comprehensive Loss
Balance, December 31, 2023	$	(4,185)	$	—	$	(4,185)
Other comprehensive income	229		—		229
Net other comprehensive income	229		—		229
Balance, March 31, 2024	$	(3,956)	$	—	$	(3,956)

	Foreign Currency Translation		Unrealized (Loss) Gain on Available for Sale Marketable Securities		Total Accumulated Other Comprehensive Loss
Balance, December 31, 2022	$	(4,098)	$	(12)	$	(4,110)
Other comprehensive income	66		13		79
Net other comprehensive income	66		13		79
Balance, March 31, 2023	$	(4,032)	$	1	$	(4,031)